Biotech

    NewLink Genetics Corporation

    NewLink Genetics Corporation

    [td_text_with_title custom_title="NewLink Genetics Corporation"]NewLink Genetics was established in 1999 by Dr Charles Link and Dr Nick Vahanian, who realized that immunotherapy was the future direction in cancer treatment. Early work in this area was focused on overcoming either the failure of the immune system to recognize cancer or the ability of the tumor to suppress the immune system. However, [...]
    0 comments
    progenics

    Progenics Pharmaceuticals

    [td_text_with_title custom_title="Progenics Pharmaceuticals Inc"]Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics' first-in-class PSMA-targeted technology platform for prostate cancer includes a small molecule imaging agent that has completed a phase 2 trial and an antibody drug conjugate therapeutic which has also completed [...]
    0 comments
    Sprint Bioscience AB

    Sprint Bioscience AB

    [td_text_with_title custom_title="Sprint Bioscience AB"]Sprint Bioscience AB is a Swedish drug development company with a mission to speed up development of novel therapies exploiting cancer metabolism and lipid signaling. Using a fragment- and structure-based approach together with a flexible company structure, Sprint Bioscience can move in just months from target selection to compounds ready for testing in cell-based assays. [...]
    0 comments
    Karo bio AB

    Karo Bio AB

    [td_text_with_title custom_title="Karo Bio AB"]Karo Bio is a development company with a focus on broadening its activities to cover projects and products closer to market. The company has several projects on the way to the clinical phase. Operations are conducted in Huddinge, Sweden and the share is listed on Nasdaq Stockholm.[/td_text_with_title] Drugs Posts not found [td_text_with_title [...]
    0 comments
    Alder Biopharmaceuticals

    Alder Biopharmaceuticals

    [td_text_with_title custom_title="Alder Biopharmaceuticals"]Today, Alder is focused on developing its pipeline of therapeutic candidates that leverage its proprietary monoclonal antibody discovery and manufacturing technologies. In May 2014, Alder completed its U.S. IPO, raising $80.1 million in net proceeds. In January 2015, Alder completed a follow-on offering resulting in gross proceeds of approximately $203.6 million, before underwriting [...]
    0 comments
    Circassia Pharmaceuticals

    Circassia Pharmaceuticals

    [td_text_with_title custom_title="Circassia Pharmaceuticals"]Circassia (CIR:LSE) is a specialty biopharmaceutical company focused on the development of novel immunotherapies. These are designed to treat a range of common allergies and autoimmune conditions by controlling patients’ inappropriate immune responses. Our most advanced treatment, Cat-SPIRE, has achieved highly impressive results in clinical studies, and is currently in the final phase of [...]
    0 comments
    Endo International plc

    Endo International plc

    [td_text_with_title custom_title="Endo International plc"]Endo International plc is a global specialty pharmaceutical company focused on improving patients’ lives while creating value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications through its operating companies – Endo Pharmaceuticals, Qualitest, AMS, Paladin Labs and SOMAR. Endo commenced operations in [...]
    0 comments
    Boston Scientific Corp

    Boston Scientific Corporation

    [td_text_with_title custom_title="Boston Scientific Corporation"]We are a leading innovator of medical solutions that improve the health of patients around the world. Our products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. We continue to innovate in these areas [...]
    0 comments
    Mallinckrodt Pharmaceuticals

    Mallinckrodt Pharmaceuticals

    [td_text_with_title custom_title="Mallinckrodt Pharmaceuticals"]Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, stemming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions [...]
    0 comments
    dbv_technologies

    DBV Technologies

    [td_text_with_title custom_title="Company description"] DBV Technologies is developing Viaskin®, an innovative new approach to the treatment of allergies – a major public health issue that has been increasing in prevalence. DBV Technologies, incorporated in France in 2002, has developed a proprietary, patented technology for administering an allergen to intact skin while avoiding transfer to the blood, [...]
    0 comments
    Horizon Pharma

    Horizon Pharma plc

    [td_text_with_title custom_title="Horizon Pharma plc"]Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  The Company markets seven medicines through its orphan, primary care and specialty business units.  Horizon’s global headquarters are in Dublin, Ireland.[/td_text_with_title] Drugs Posts not found [...]
    0 comments
    Zimmer Biomet

    Zimmer Biomet

    [td_text_with_title custom_title="Zimmer Biomet"]Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. Zimmer Biomet design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet collaborate with healthcare professionals [...]
    0 comments
    Sigma Aldrich Corporation

    Sigma-Aldrich Corporation

    [td_text_with_title custom_title="Sigma-Aldrich Corporation"]Sigma-Aldrich, a leading Life Science and Technology company focused on enhancing human health and safety, manufactures and distributes 230,000 chemicals, biochemicals and other essential products and 40,000 equipment products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets.  With three distinct business [...]
    0 comments
    Tornier

    Tornier Inc

    [td_text_with_title custom_title="Tornier Inc"]Tornier is a global medical device company focused on serving extremities specialists that treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The company’s broad offering of over 100 product lines includes joint replacement, trauma, sports medicine, and orthobiologic products to treat the extremities, as well as joint replacement products [...]
    0 comments
    Wright Medical Technology

    Wright Medical Technology Inc.

    [td_text_with_title custom_title="Wright Medical Technology Inc."]We are a global orthopaedic company that provides solutions that enable clinicians to alleviate pain and restore their patients' lifestyles. We are a recognized leader of surgical solutions for the foot and ankle market and market our products in over 60 countries worldwide. Our business includes products that are used primarily [...]
    0 comments
    Northwest Biotherapeutics

    Northwest Biotherapeutics Inc

    [td_text_with_title custom_title="Northwest Biotherapeutics Inc"]NW Bio is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs. NW Bio’s proprietary manufacturing technology enables the Company to produce its personalized vaccine in an efficient, cost-effective manner. The Company has a broad [...]
    0 comments
    Flexus Biosciences takeover

    Flexus Biosciences Inc

    [td_text_with_title custom_title="Company description"]Founded in 2013, Flexus is a biotechnology company focused on the discovery, development, and commercialization of small-molecule cancer immunotherapies targeting regulatory T cells. The company is leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression (ARTIS). This disruptive approach to cancer therapy targets that which is common to all tumors, [...]
    0 comments
    Salix Pharmaceuticals takeover

    Salix Pharmaceuticals Ltd

    [td_text_with_title custom_title="Company description"]Salix Pharmaceuticals is a specialty pharmaceutical company that offers innovative gastroenterology treatments. The company are committed to licensing, developing, and marketing products to treat gastroenterology disorders. It is their mission to give healthcare professionals and patients the most effective solutions in gastroenterology.[/td_text_with_title] Drugs Posts not found [td_text_with_title custom_title="Latest post"] Valeant Acquire Salix Pharmaceuticals For $158.00 [...]
    0 comments
    Ligand Investing

    Ligand Pharmaceuticals

    [td_text_with_title custom_title="Company description"] About Ligand Ligand's business is focused on developing programs that lead to licensing deals or acquiring royalty revenue-generating assets and coupling them to an efficient, lean corporate cost structure. Ligand's goal is to produce a bottom line that generates sustainable profits and positive cash-flow. By diversifying the portfolio of assets across numerous [...]
    0 comments
    Biotec Pharmacon

    Biotek Pharmacon

    [td_text_with_title custom_title="Company description"]Biotec Pharmacon develops, manufactures and markets immune modulating compounds for the human health sectors and marine enzymes used in molecular biology. The company is spearheading research on products that may prevent or treat diseases caused by failure, imbalance and over-reaction of the immune system. The company has invested heavily in R&D and generated [...]
    0 comments
    oasmia-logo

    Oasmia Pharmaceutical AB

    [td_text_with_title custom_title="Company description"] Improved quality of life for humans and animals Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. [...]
    0 comments
    Dyax

    Dyax Corp.

    [td_text_with_title custom_title="Company description"]Dyax is a biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs. The Company is developing DX-2930, a fully human monoclonal antibody, for the prevention of HAE attacks. In March 2015, the Company reported positive safety, pharmacokinetic, biomarker and proof-of-concept efficacy results from its Phase 1b clinical trial of [...]
    0 comments
    Natera_investment

    Natera

    [td_text_with_title custom_title="Company description"]Natera is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. We operate a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California, and currently offer a host of proprietary genetic testing services. Natera’s goal is to change the way people – both providers and [...]
    0 comments
    sarepta_investment

    Sarepta Therapeutics

    [td_text_with_title custom_title="Company description"]Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. Our diverse pipeline includes eteplirsen, our lead program for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most lethal infectious diseases. We [...]
    0 comments
    Santhera_investment

    Santhera

    [td_text_with_title custom_title="Company description"]Santhera is focusing on the development and commercialization of innovative treatments of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy. Strategically, Santhera focuses on Raxone®/Catena® (INN: idebenone) in mutliple indications.[/td_text_with_title] Drugs Idebenone Posted: Jul 2, 2015 Idebenone is Santhera's lead [...]
    0 comments
    Biomarin_investments

    Biomarin

    [td_text_with_title custom_title="Company description"]BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises five approved products and multiple clinical and pre-clinical product candidates. Approved products include Vimizim® (elosulfase alfa) for MPS IVA, a product wholly developed and commercialized by BioMarin; Naglazyme® (galsulfase) for MPS VI, a product wholly developed [...]
    0 comments
    zynerba-pharmaceuticals

    Zynerba Pharmaceuticals

    [td_text_with_title custom_title="About"]Our mission is to improve the lives of patients battling severe health conditions including epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain through these therapeutics. Our development pipeline includes patent-protected synthetic transdermal cannabinoid products, which we believe will provide new treatment options for patients as well as additional treatment options for patients [...]
    0 comments
    Cellectis

    Cellectis

    [td_text_with_title custom_title="Company description"]Cellectis is a preclinical stage biopharmaceutical company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART). The company’s mission is to develop a new generation of cancer therapies based on engineered T-cells. Cellectis capitalizes on its 15 years of expertise in genome engineering - based on its flagship TALEN® products [...]
    0 comments
    Bellicum_Pharmaceuticals_ipo

    Bellicum Pharmaceuticals

    [td_text_with_title custom_title="Company description"]Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders.  [/td_text_with_title] Drugs Posts not found [td_text_with_title custom_title="Latest post"] Posts not found[/td_text_with_title]
    0 comments
    Kite Pharma

    Kite Pharma

    [td_text_with_title custom_title="Company description"]Kite Pharma´s goal is to be a leader in immunotherapy in multiple cancer indications. To achieve this, we are developing a pipeline of product candidates for the treatment of advanced solid and hematological malignancies using our therapeutic platform – engineered Autologous Cell Therapy (eACT™) – in which a patient’s own T cells, or white [...]
    0 comments
    Cellgene_investment

    Celgene

    [td_text_with_title custom_title="Company description"]Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit www.celgene.com. Follow Celgene on Social Media: @Celgene, Pinterest, LinkedInand YouTube.[/td_text_with_title] Drugs [...]
    0 comments
    BioPharmX

    BioPharmX

    [td_text_with_title custom_title="Company description"]BioPharmX, Inc. provides innovative healthcare products through its unique, patented platform technologies for pharmaceutical, over-the-counter (OTC), and supplement applications. BioPharmX products address unmet needs in large, well-defined and under-served global markets including: Dermatology Aesthetics Women’s health At BioPharmX, we aim to touch lives by providing relief and restoring well-being.[/td_text_with_title][td_text_with_title custom_title="Latest post"] BioPharmX raising [...]
    0 comments
    Bavarian_Nordic_investment

    Bavarian Nordic

    [td_text_with_title custom_title="Company description"]Bavarian Nordic is a biopharmaceutical company focused on the development and manufacturing of cancer immunotherapies and vaccines for infectious diseases.[/td_text_with_title] Drugs Posts not found [td_text_with_title custom_title="Latest post"] Potential Combination Strategies for Active Immunotherapy in Prostate Cancer Posted: Jun 25, 2015 From Bavarian Nordic   FacebookLinkedInTwitterEmailPrint 0 comments Kerrisdale Advisers LLC short 2,23 % [...]
    0 comments
    logo@2x

    Benitec Biopharma

    [td_text_with_title custom_title="Company description"]Benitec Biopharma has developed a breakthrough platform — ddRNAi — for treating human diseases. Unlike other RNAi-based technologies, ddRNAi effects lasting change in target cells, leading to long term benefit and potentially cure.[/td_text_with_title][td_text_with_title custom_title="Latest post"] Benitec Biopharma sets price at 13-13.06 $ Posted: Aug 2, 2015 Benitec Biopharma, which is developing gene therapies [...]
    0 comments
    cynapsus-logo

    Cynapsus Therapeutics

    [td_text_with_title custom_title="Company description"]Cynapsus is a specialty pharmaceutical company developing a convenient and easy-to-use sublingual thin filmstrip for the acute rescue of OFF motor symptoms of Parkinson’s disease. More than 1 million people in the U.S. and an estimated 4 to 6 million people globally suffer from Parkinson's disease. Parkinson’s disease is a chronic and progressive [...]
    0 comments
    biocardia_ipo

    Biocardia

    [td_text_with_title custom_title="Company description"]We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia is developing proprietary comprehensive  biotherapeutic solutions for cardiovascular disease in its CardiAMP™ and CardiALLO™ therapies. Clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with [...]
    0 comments
    celyad_ipo

    Celyad

    [td_text_with_title custom_title="Company description"]Celyad – previously Cardio3 BioSciences – is a biopharmaceutical company focused on translating breakthrough cell-based research into innovative therapeutics to improve the outcome of severe diseases. The Company is currently developing  clinical stage cell therapies in cardiology[/td_text_with_title] [td_text_with_title custom_title="Latest post"] Celyad Posted: Jun 19, 2015 Celyad, a Belgian biotech developing gene therapies for [...]
    0 comments
    VTV_ipo

    vTv Therapeutics

    [td_text_with_title custom_title="Company description"]vTv Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. Our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. We have a pipeline of small molecule clinical and pre-clinical [...]
    0 comments
    Chiasma_ipo

    Chiasma

    [td_text_with_title custom_title="Company description"]Chiasma is a biopharmaceutical company focused on evolving orphan medications to better meet the needs of patients and healthcare professionals. Our first priority is the development and commercialization of octreotide capsules – the only oral somatostatin analog. This means the chance to avoid painful needles and minimize symptoms that can arise as traditional injections [...]
    0 comments
    Taimed_investing

    Taimed

    [td_text_with_title custom_title="Company Description"] TaiMed Biologics was formed on September 4, 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy the unmet medical needs of patients around the world. The company signed an agreement with Genentech for the licensing of Ibalizumab shortly after its formation. This drug candidate, also known as [...]
    0 comments
    Seres_investment

    Seres Therapeutics

    [td_text_with_title custom_title="Company description"]Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic® therapeutic products to treat important diseases by targeting the underlying biology of the human microbiome. Seres is developing the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span metabolic, inflammatory, and [...]
    0 comments
    Aduroa Biotech

    Aduro Biotech

    [td_text_with_title custom_title="Company description"]Aduro is a clinical-stage cancer immunotherapy company with three products currently in human trials. The company’s lead candidate – an immunotherapy regimen combining our proprietary CRS-207 with GVAX Pancreas – is targeting metastatic pancreatic cancer and has received Breakthrough Therapy designation from the US Food and Drug Administration. CRS-207 is the first therapeutic [...]
    0 comments
    pharmacyclics

    Pharmacyclics Inc.

    [td_text_with_title custom_title="Company description"]Pharmacyclics, Inc. (Ticker: PCYC) a proud member of the AbbVie family, aiming to apply their combined scientific expertise, commercial experience, operational integrity, and organizational tenacity to help fulfill the company promise of providing targeted and patient-friendly therapies. Pharmacyclics believe in truly serving patients, their families, and caregivers.[/td_text_with_title] Drugs Ibrutinib Posted: Apr 8, 2013 [...]
    0 comments
    Vertex Pharmaceuticals

    Vertex Pharmaceuticals Inc

    [td_text_with_title custom_title="Company description"]Vertex Pharmaceuticals, Inc. (Ticker: VRTX) is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to their clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and [...]
    0 comments
    Intermune Logo

    InterMune Inc

    [td_text_with_title custom_title="Company description"]InterMune Inc. is a publicly traded (Ticker: ITMN) biotechnology company, which has its Global headquarters in San Francisco in the United States and its European headquarters in Switzerland. Our focus is on the research and development of innovations in the field of respiratory and orphan fibrotic diseases. In respiratory, the company are focused [...]
    0 comments
    Intercept Pharmaceuticals Inc

    Intercept Pharmaceuticals

    [td_text_with_title custom_title="Company description"]Intercept Pharmaceuticals, Inc. (Ticker: ICPT) are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases utilizing the proprietary bile acid chemistry. The product candidates have the potential to treat orphan and more prevalent diseases for which there currently are limited therapeutic solutions. [/td_text_with_title] Drugs Obeticholic [...]
    0 comments
    Juno therapeutics inc

    Juno Therapeutics Inc.

    [td_text_with_title custom_title="Company description"]Juno Therapeutics, Inc. (Ticker JUNO) is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Juno Therapeutics aims to revolutionize medicine by re-engaging the body’s immune system to treat cancer. The use of human T cells as therapeutics [...]
    0 comments
    bluebird bio inc

    Bluebird bio Inc

    [td_text_with_title custom_title="Company description"]Bluebird bio, Inc. (Ticker: BLUE) is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, Bluebird bio Inc. has operations in the U.S. [...]
    0 comments
    synageva biopharma corp

    Synageva BioPharma Corp.

    [td_text_with_title custom_title="Company description"]Synageva BioPharma Corp. (Ticker: GEVA) is a biopharmaceutical company dedicated to discovering, developing and delivering medicines for patients with rare diseases and high unmet medical needs. The company are passionate about their commitment to improving the lives of patients for generations to come. The experienced team at Synageva BioPharma has developed and delivered [...]
    0 comments
    Neurocrine Biosciences

    Neurocrine Biosciences Inc.

    [td_text_with_title custom_title="Company description"]Neurocrine Biosciences, Inc. (Ticker: NBIX) discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company’s two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women’s health that is partnered with [...]
    0 comments
    Acadia Pharmaceuticals

    Acadia Pharmaceuticals Inc.

    [td_text_with_title custom_title="Company description"]Acadia Pharmaceuticals, Inc. (Ticker: ACAD), are passionate about improving the lives of patients with neurological and related central nervous system (CNS) disorders. The Acadia Pharmaceuticals pipeline is led by the product candidates NUPLAZIDTM (pimavanserin), which, if approved, will establish a new and distinctly different pharmacological approach to treating psychosis and be the only [...]
    0 comments
    celldex_investments

    Celldex Therapeutics Inc.

    [td_text_with_title custom_title="Company description"]Celldex Therapeutics (Ticker: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have [...]
    0 comments
    clovis_investment

    Clovis Oncology Inc.

    [td_text_with_title custom_title="Company description"]Clovis Oncology, Inc (Ticker: CLVS) are a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. The development programs are targeted at specific subsets of cancer, combining personalized medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from [...]
    0 comments
    portola pharmaceuticals inc

    Portola Pharmaceuticals Inc.

    [td_text_with_title custom_title="Company description"]Portola Pharmaceuticals, Inc. (Ticker: PTLA) was founded in 2003 and is headquartered in South San Francisco, Calif. Portola Pharmaceuticals completed an initial public offering in May 2013 and are traded on the Nasdaq Stock Market under the symbol PTLA. Portola Pharmaceuticals are approximately 95 employees. The company aim to build an enduring biopharmaceutical [...]
    0 comments
    Spark Therapeutics

    Spark Therapeutics Inc.

    [td_text_with_title custom_title="Company description"]Spark Therapeutics (Ticker: ONCE) is developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases. Spark is a leader in the field of gene therapy, seeking to transform the lives of patients by developing one-time, life-altering treatments for debilitating genetic diseases. We initially are [...]
    0 comments
    ARIAD Pharmaceuticals

    ARIAD Pharmaceuticals Inc.

    [td_text_with_title custom_title="Company description"]ARIAD is a global biotechnology company focused exclusively, passionately, on cancer. ARIAD Pharmaceuticals Inc. (Ticker: ARIA), headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms [...]
    0 comments
    Insmed Incorporated

    Insmed Incorporated

    [td_text_with_title custom_title="Company description"]Insmed Incorporated (Ticker: INSM) are focused on developing and commercializing drugs that treat orphan disease populations. Investment Thesis. Leading product candidate, ARIKAYCE, is being developed for patients with severe lung infections. ARIKAYCE is a proprietary inhaled liposomal formulation of the antibiotic amikacin, currently administered intravenously for a range of infections. The product is [...]
    0 comments
    Atara Biotherapeutics

    Atara Biotherapeutics Inc.

    [td_text_with_title custom_title="Company description"]Atara Biotherapeutics Inc. (Ticker: ATRA) were launched in August 2012 to help patients combat cancer, kidney disease and other illnesses. Our research is based on groundbreaking discoveries regarding the ability of activin, myostatin and other growth factors to change the course of disease progression. Our goal is to help patients such as Atara [...]
    0 comments
    Celladon Corporation

    Celladon Corporation

    [td_text_with_title custom_title="Company description"]Celladon Corporation (Ticker: CLDN) are a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy. On June 1, 2015, Celladon Corporation announced that our Board of Directors had approved a strategic plan pursuant to which they would immediately commence a process to seek an acquisition or partnership. Our lead [...]
    0 comments
    Catalyst Pharmaceutical Partners

    Catalyst Pharmaceutical Partners Inc

    [td_text_with_title custom_title="Company description"]Catalyst Pharmaceutical Partners Inc. (Catalyst Pharmaceuticals Ticker: CPRX), is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. Catalyst's lead program, Firdapse®, is currently in the late stages of a pivotal phase III, global, multi-centered trial for the treatment of patients with Lambert - Eaton Myasthenic [...]
    0 comments
    exiqon_investment

    Exiqon

    [td_text_with_title custom_title="Company description"]Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and the development of cancer and other [...]
    0 comments
    astellas-pharma-logo

    Astellas Pharma

    [td_text_with_title custom_title="Company description"]Astellas Pharma US, Inc., is the U.S. affiliate of Astellas Pharma Inc., a R&D-driven global pharmaceutical company. At Astellas, we improve lives through innovative and effective medicines. Our dedication to changing tomorrow for patients and our customers fits closely with our strong scientific orientation and focus on the community in which we work and live.[/td_text_with_title] [...]
    0 comments
    Veloxis

    Veloxis Pharmaceuticals

    [td_text_with_title custom_title="Company description"]Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis' unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.[/td_text_with_title] Drugs Envarsus [...]
    0 comments
    SPPI_investment

    Spectrum Pharmaceuticals

    [td_text_with_title custom_title="Company description"]Our primary strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to building an efficient in-house clinical development organization with regulatory and data management capabilities, Spectrum has established a commercial infrastructure for its marketed products. We have five oncology/hematology products on the [...]
    0 comments
    logo-onxeo-grand

    Onxeo

    [td_text_with_title custom_title="Company description"]Onxeo was created through the merger of BioAlliance Pharma, a French innovative company based in Paris specializing in the development of drugs for orphan diseases in oncology, with Topotarget, a Danish biopharmaceuticals company based in Copenhagen, also a specialist in the development of oncology products. The company is listed on both Euronext Paris [...]
    0 comments
    Topotarget

    TopoTarget

    [td_text_with_title custom_title="Company description"][/td_text_with_title] Drugs Posts not found [td_text_with_title custom_title="Latest post"] Onxeo årsrapport 2014 Posted: Apr 15, 2015 Onxeo blev skabt i midten af 2014 gennem fusionen mellem BioAlliance Pharmas og Topotarget sidstnævnte, en dansk biofarmaceutisk virksomhed med base i København. Onxeo stiler efter at blive en vigtig spiller inden for lægemidler til behandling af sjældne [...]
    0 comments
    Zealand investment

    Zealand Pharma

    [td_text_with_title custom_title="Company description"]Zealand Pharma A/S (“Zealand”) (Nasdaq Copenhagen: ZEAL) is a biotechnology company based in Copenhagen, Denmark. Zealand has leading expertise in the discovery, design and development of novel peptide medicines and possesses in-house competences in clinical trial design and management with a therapeutic focus on metabolic diseases and acute care indications. The company is advancing [...]
    0 comments
    genmab-logo

    Genmab

    [td_text_with_title custom_title="Company description"]Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.   Founded in 1999, the company currently has one marketed antibody, Arzerra® (ofatumumab) for the treatment of certain chronic lymphocytic leukemia indications and daratumumab in late stage clinical development [...]
    0 comments
    logoemp

    Pluristem Therapeutics

    [td_text_with_title custom_title="Company Description"] Our vision at Pluristem Therapeutics is to leverage our position as a global leader in placenta-based cell science to develop and manufacture safe and effective cell therapy products. We believe our cutting edge technology can produce therapies that will help people affected by inflammation, ischemia, hematological disorders, and acute radiation syndrome, and [...]
    0 comments
    Hester Biosciences Ltd

    Hester Biosciences Ltd

    [td_text_with_title custom_title="Hester Biosciences Ltd"]Hester Biosciences Limited is an India-based company, engaged in the manufacturing of animal vaccines and health products. The products of the Company include vaccines, health products and diagnostics. These products are offered under categories avian, swine and large animal. Its services include seroprofiling for poultry flocks and mastitis control programs for cattle. [...]
    0 comments